跳至主要内容
临床试验/IRCT20240107060640N1
IRCT20240107060640N1招募中Unknown

Effects of Low-Level Laser therapy with two visible and Infrared wavelengths in the treatment of the symptoms of the Chemo-Therapy Induced Peripheral Neuropathy

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Cancer patients who took the following chemotherapy drugs during treatment: 1. Platinum compounds 2. Vinca alkaloids3. Bortezomib 4. Taxans 5. Fluorouracil6. Thalidomide, lenalidomide
  • At least 6 months have passed since the end of the patient's chemotherapy.
  • The signs and symptoms of the disease have caused a decrease in the patient's quality of life.
  • Filling out the Toronto questionnaire

排除标准

  • Entry into the study is subject to the absence of neuropathy due to other causes of neuropathy, including diabetes, radiculopathies, hereditary and acquired neuropathies, which can be verified at the beginning of the study through history and NCV.

研究者

相似试验